Showing results (41-50 of 260) with videos related to
Sort By:
Pageof 26
Clinical Pharmacokinetics|November 15, 2012
The clinical relevance of plasma protein binding changesJason A Roberts, Federico Pea, Jeffrey LipmanClinical Pharmacokinetics|October 30, 2017
Population Pharmacokinetics and Dosing Considerations for the Use of Linezolid in Overweight and Obese Adult PatientsPiergiorgio Cojutti, Manjunath P Pai, Federico PeaClinical Pharmacokinetics|June 9, 2016
Pharmacokinetics and Dosing of Ceftobiprole Medocaril for the Treatment of Hospital- and Community-Acquired Pneumonia in Different Patient PopulationsAntonio Torres, Johan Willem Mouton, Federico PeaJournal of Global Antimicrobial Resistance|August 22, 2024
Piperacillin-tazobactam vs. carbapenems for treating hospitalized patients with ESBL-producing Enterobacterales bloodstream infections: A systematic review and meta-analysisMilo Gatti, Pier Giorgio Cojutti, Federico PeaExpert Review of Anti-Infective Therapy|March 10, 2015
Treatment options for community-acquired pneumonia in the elderly peopleNicola Petrosillo, Maria Adriana Cataldo, Federico PeaAdvanced Drug Delivery Reviews|July 20, 2014
The effect of pathophysiology on pharmacokinetics in the critically ill patient--concepts appraised by the example of antimicrobial agentsStijn I Blot, Federico Pea, Jeffrey LipmanCritical Care (London, England)|April 16, 2024
Impact of attaining aggressive vs. conservative PK/PD target on the clinical efficacy of beta-lactams for the treatment of Gram-negative infections in the critically ill patients: a systematic review and meta-analysisMilo Gatti, Pier Giorgio Cojutti, Federico PeaFundamental & Clinical Pharmacology|April 11, 2003
MEGX disposition in critically-ill trauma patients: subsequent assessments during the first week following traumaFederico Pea, Maurizia Licari, Marco Baldassarre, et al.Frontiers in Oncology|November 16, 2020
Sonidegib for the Treatment of Advanced Basal Cell CarcinomaGabriella Brancaccio, Federico Pea, Elvira Moscarella, et al.International Journal of Antimicrobial Agents|May 13, 2017
Limited sampling strategies for determining the area under the plasma concentration-time curve for isoniazid might be a valuable approach for optimizing treatment in adult patients with tuberculosisPiergiorgio Cojutti, Manuela Giangreco, Miriam Isola, et al.Pageof 26